Jeanine M L Roodhart

14PUBLICATIONS
62CO-AUTHORS
Molecular targetsPredictive and prognostic markersModels of care and place of birthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 07, 2026
Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Maarten A Huismans, Eelke H Gort, Lisa T van der Heijden

|Jan 09, 2026
Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study.

Carmen Rubio-Alarcón, Andrew Georgiadis, Ingrid A Franken

|Sep 22, 2025
Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer.

Lidwien P Smabers, G Emerens Wensink, Carla S Verissimo

|Sep 08, 2025
A comparison by mismatch repair status of real-world characteristics and outcomes in patients with stage II/III rectal cancer in the Netherlands.

Renee A Lunenberg, Ingrid A Franken, Frederieke H van der Baan

|Mar 13, 2025
Real-world treatment patterns and outcomes based on RAS/BRAF status in metastatic colorectal cancer-Analysis of the Prospective Dutch Colorectal Cancer cohort.

Sietske C M W van Nassau, Koen Zwart, Frederieke H van der Baan

|Aug 08, 2024
Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer.

Simone van de Weerd, Arezo Torang, Inge van den Berg

Pageof 3

Frequent Collaborators

8 joint publications

Miriam Koopman

4 joint publications

Maarten A Huismans

3 joint publications

G Emerens Wensink

3 joint publications

Ingrid A Franken